STAT3 and medulloblastoma: In particular, the interleukin-6 (IL6)/gp130/Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) signaling pathway has been implicated in the development of chemoresistance to vincristine in group 3 medulloblastomas [121,122].